|19th January 2021||Andrew Marsh||106,600||Exercise of derivative||$6.10||$650,260.00|
|19th January 2021||Andrew Marsh||49,918||Open or private sale||$63.97||$3,193,054.79|
|19th January 2021||Andrew Marsh||114,120||Open or private sale||$65.66||$7,493,256.14|
|19th January 2021||Andrew Marsh||466,668||Exercise of derivative||$2.14||$998,669.52|
|19th January 2021||Andrew Marsh||156,051||Open or private sale||$64.82||$10,115,163.40|
|19th January 2021||Andrew Marsh||13,482||Open or private sale||$62.65||$844,652.69|
|19th January 2021||Andrew Marsh||5,178||Open or private sale||$68.31||$353,713.84|
|19th January 2021||Andrew Marsh||101,766||Open or private sale||$67.73||$6,892,305.88|
|19th January 2021||Andrew Marsh||132,753||Open or private sale||$66.58||$8,838,708.02|
|16th December 2020||L Lynn Smull||9,834||Payment by withholding||$2.17||$21,339.78|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Gevo, Inc. is a renewable chemicals and next generation biofuels company. The company focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments. The Gevo segment focuses in research and development activities related to the future production of isobutanol.